AU1761601A - Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain - Google Patents
Inhibition of angiogenesis by antibodies against high molecular weight kininogen domainInfo
- Publication number
- AU1761601A AU1761601A AU17616/01A AU1761601A AU1761601A AU 1761601 A AU1761601 A AU 1761601A AU 17616/01 A AU17616/01 A AU 17616/01A AU 1761601 A AU1761601 A AU 1761601A AU 1761601 A AU1761601 A AU 1761601A
- Authority
- AU
- Australia
- Prior art keywords
- angiogenesis
- inhibition
- molecular weight
- high molecular
- antibodies against
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16516599P | 1999-11-12 | 1999-11-12 | |
US60165165 | 1999-11-12 | ||
PCT/US2000/030975 WO2001034195A1 (en) | 1999-11-12 | 2000-11-10 | Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1761601A true AU1761601A (en) | 2001-06-06 |
Family
ID=22597715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU17616/01A Abandoned AU1761601A (en) | 1999-11-12 | 2000-11-10 | Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1227842A4 (en) |
AU (1) | AU1761601A (en) |
WO (1) | WO2001034195A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050124794A1 (en) * | 2002-03-15 | 2005-06-09 | Mccrae Keith | Cell surface tropomyosin as a target of angiogenesis inhibition |
WO2008091692A2 (en) * | 2007-01-25 | 2008-07-31 | Joslin Diabetes Center, Inc. | Methods of diagnosing, treating, and preventing increased vascular permeability |
CA3008621A1 (en) | 2015-12-15 | 2017-06-22 | Dyax Corp. | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4908431A (en) * | 1986-01-22 | 1990-03-13 | Temple University-Of The Commonwealth System Of Higher Education | Monoclonal antibodies to human kininogen and methods of preparing same |
AU773862B2 (en) * | 1998-11-10 | 2004-06-10 | Temple University - Of The Commonwealth System Of Higher Education | Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof |
-
2000
- 2000-11-10 AU AU17616/01A patent/AU1761601A/en not_active Abandoned
- 2000-11-10 EP EP00980341A patent/EP1227842A4/en not_active Withdrawn
- 2000-11-10 WO PCT/US2000/030975 patent/WO2001034195A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001034195A1 (en) | 2001-05-17 |
EP1227842A1 (en) | 2002-08-07 |
EP1227842A4 (en) | 2005-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3606399A (en) | Increasing the molecular weight of polyesters | |
AU1660901A (en) | Device for the inhibition of cellular proliferation | |
AU2600800A (en) | Promotion or inhibition of angiogenesis and cardiovascularization | |
AU1571401A (en) | Deposition of fluorosilsesquioxane films | |
AU2567300A (en) | Inhibition of angiogenesis with epigallocatechin-3-gallate | |
AU1530001A (en) | Inhibitor compositions | |
AU7947000A (en) | Tricyclic fused-imidazole derivatives | |
AU6527300A (en) | Potentiation of inclusion complex formation of cyclodextrin derivatives | |
AU4329600A (en) | Wall protection from downward flowing solids | |
AU2596700A (en) | Promotion or inhibition of angiogenesis and cardiovascularization | |
AU1740601A (en) | Conveyor track of the smart-track type | |
AU5429000A (en) | Novel bicyclonucleoside derivatives | |
AU3670000A (en) | Novel thiazolobenzimidazole derivatives | |
AU2730801A (en) | Survivin promotion of angiogenesis | |
AU6615500A (en) | Preventing immune-mediated abortion by inhibiting costimulation | |
AU1569501A (en) | Beta-aminoacid compounds useful for inhibiting beta-amyloid peptide release and/or its synthesis | |
AU1761601A (en) | Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain | |
AU4369000A (en) | Inhibition of complement action | |
AU5568400A (en) | Novel dihydropyrimidine derivatives | |
AU4440199A (en) | Methods and compositions for inhibition of angiogenesis | |
AU3429500A (en) | Pipe coatings | |
AU5166700A (en) | C-cam as an angiogenesis inhibitor | |
AU1304801A (en) | Tricyclic azaindolizine derivatives having an SPLA2- inhibiting effect | |
AU5252900A (en) | Novel isocoumarin derivatives inhibiting angiogenesis | |
AU7348998A (en) | Inhibition of angiogenesis by verotoxins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |